IL21-AS1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, IL21-AS1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated IL21-AS1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher IL21-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IL21-AS1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

KIRP, HNSC, and SKCM are the cancer types where IL21-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRPOSMedianAll0.5460.812<.001187view →
HNSCDFSMedianAll0.7560.634<.001134view →
SKCMOSTertileAll0.4500.271<.001108view →
LUADDFSQuartileIII,IV0.8870.529<.00183view →
CESCDFSMedianAll0.8770.763.00362view →
LGGOSMedianAll0.7420.866<.00151view →
BLCAOSMedianAll0.7720.655.00244view →
READDFSMedianII,III,IV0.5410.773.00341view →
KIRCDFSTertileAll0.7110.879.00138view →
UCECOSQuartileAll0.7820.600.00834view →
KICHDFSTertileIII,IV0.2851.000.00625view →
LUSCDFSQuartileII,III,IV0.6150.788.00521view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

Exploration